USNA logo

USANA Health Sciences Inc. (USNA)

$21.82

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on USNA

Market cap

$398888300

EPS

0.88

P/E ratio

24.6

Price to sales

0.43

Dividend yield

--

Beta

0.668522

Price on USNA

Previous close

$21.67

Today's open

$21.82

Day's range

$21.29 - $22.19

52 week range

$18.48 - $38.32

Profile about USNA

CEO

Kevin Guest

Employees

1700

Headquarters

Salt Lake City, UT

Exchange

New York Stock Exchange

Shares outstanding

18280857

Issue type

Common Stock

USNA industries and sectors

Consumer Staples

Consumer Products - Healthcare

News on USNA

USNA or UTHR: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and United Therapeutics (UTHR). But which of these two stocks is more attractive to value investors?

news source

Zacks Investment Research • Feb 23, 2026

news preview

USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript

USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript

news source

Seeking Alpha • Feb 18, 2026

news preview

USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and fiscal year ended January 3, 2026. Key Financial and Operating Results   Q4 2025   Q4 2024   FY 2025   FY 2024 Net sales $226.2   $213.6   $925.3   $854.5 Net (loss) earnings* $-1.8   $4.5   $10.8   $42.0 Diluted EPS $-0.10   $0.23   $0.58   $2.19 Adjusted diluted EPS(1) $0.60   $0.64   $1.93   $2.59 Adjusted EBITDA(2) $27.3   $25.5   $101.3   $110.3 USAN.

news source

Business Wire • Feb 17, 2026

news preview

USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates

USANA Health Sciences (USNA) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.64 per share a year ago.

news source

Zacks Investment Research • Feb 17, 2026

news preview

Analysts Estimate USANA Health Sciences (USNA) to Report a Decline in Earnings: What to Look Out for

USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

news source

Zacks Investment Research • Feb 10, 2026

news preview

USANA Exec. Chairman/CEO Kevin Guest on Self-Renewal Day: Break Comfort Zones for Strategic Growth with Six Steps

SALT LAKE CITY, Feb. 2, 2026 /PRNewswire/ -- As organizations face rapid market disruption and evolving leadership demands, Feb. 2 marks Self-Renewal Day, a pivotal time for business leaders to recalibrate strategies and personal development. "Growth does not happen by accident; it happens by choice," said  Kevin Guest, Executive Chairman & CEO at USANA Health Sciences (NYSE: USNA).

news source

PRNewsWire • Feb 2, 2026

news preview

USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary fiscal year 2025 net sales and initial net sales guidance for fiscal year 2026 ahead of its presentation at the 28th Annual ICR Conference. At the conference, Doug Hekking, CFO, and Walter Noot, COO, will discuss USANA's strategy, including the Company's initial fiscal year 2026 sales outlook. Preliminary Fiscal Year 2025 Net Sales Results The Company currently anticipates fiscal year 2025 cons.

news source

Business Wire • Jan 12, 2026

news preview

Kevin Guest Returns to USANA Health Sciences as CEO

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) announced today a leadership transition as part of the Company's ongoing commitment to accelerating growth and enhancing shareholder value. Kevin Guest is returning to lead the Company as Chief Executive Officer, effective immediately. Mr. Guest, who has spent more than three decades at the Company, including eight years as CEO and the last three years as Executive Chairman, has agreed to again serve as USANA's CEO and wi.

news source

Business Wire • Jan 8, 2026

news preview

USANA Executive Chairman Kevin Guest Shares Timeless Lessons for a 2026 Growth Mindset

SALT LAKE CITY, Jan. 5, 2026 /PRNewswire/ -- As leaders everywhere set sights on the new year, Kevin Guest, Executive Chairman at USANA Health Sciences (NYSE: USNA), is encouraging professionals to embrace a growth mindset as the key to lasting achievement and fulfillment. "Success is about the experiences you have, the relationships you build, and the lessons you apply," said Guest, who is also the author of the bestseller, All the Right Reasons: 12 Principles for Living a Life in Harmony.

news source

PRNewsWire • Jan 5, 2026

news preview

USANA Foundation Shares Holiday Cheer with Meals for Utah Students and Families

More than 5,100 food bags delivered to help support children during winter break SALT LAKE CITY , Dec. 23, 2025 /PRNewswire/ -- The holiday season is meant to be a time of celebration, yet for many children who depend on school meals, extended breaks can bring uncertainty. To help bridge that gap, the USANA Foundation - through its Utah-focused Kids Eat program - once again mobilized its annual holiday food pack initiative to help ensure families across Utah had access to nutritious meals while school was out of session.

news source

PRNewsWire • Dec 23, 2025

news preview

¹ Disclosures

Get started with M1

Invest in USANA Health Sciences Inc.

Open an M1 investment account to buy and sell USANA Health Sciences Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in USNA on M1